NCT01098955View on ClinicalTrials.gov

Smoking Cessation Treatment for Head & Neck Cancer Patients

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 24, 2010

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Head and Neck CancerSmoking Cessation
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

6 x 60-minute counseling sessions delivered over a 5-week period

BEHAVIORAL

Motivational and Behavioral Counseling

6 x 60-minute counseling sessions delivered over a 5-week period

DRUG

Varenicline

2 mg daily for 12 weeks

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER